• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Markets

Omicron Uncertainty Is Causing Fresh Selling

The challenge for traders is determining how long the Omicron uncertainty will weigh on the markets.
By JAMES "REV SHARK" DEPORRE
Nov 30, 2021 | 06:50 AM EST
Stocks quotes in this article: MRNA, REGN

The market is selling off Tuesday morning following comments from the CEO of Moderna (MRNA) that its vaccine may be less effective against the Omicron variant of Covid-19. There is still much research to be done, but the uncertainty created by these comments is triggering selling pressure.

In addition to Moderna, there are comments from Regeneron (REGN) that its antibody-drug cocktail was found to lose effectiveness against the variant and may need modification.

Despite these comments, the early indications are that the Omicron variant may be more contagious but less severe. There is still a tremendous amount that is unknown, and as the saying goes, the market hates uncertainty.

The senior indexes did an excellent job of shrugging off some of the worries on Monday, but it was a deceptive day with weak breadth, more stocks hitting new 12-month lows, and weakness in growth stocks and small-caps. The theme of a small group of big-cap names holding up the indexes continued to dominate the action.

The problem the market is going to grapple with is the uncertainty of Omicron. Monday there was optimism that it could be handled well, but Tuesday morning the comments from the drug companies are causing concern. There is very little hard data, and most of the words are just speculation, but it is causing increased worries.

The challenge for market players is determining how long the Omicron uncertainty will weigh on the markets. There are still no reports of a U.S. case, which may cause additional pressure when that headline hits.

From a trading standpoint, the most significant issue to consider right now is the two-tiered nature of the market. On the one hand, there is a bear market in much of the market, but it is hidden behind the indexes and big caps, which some pundits call a bubble. If the indexes represented the average stock, all the headlines would be talking about a bear market and the potential for a low, but the indexes have corrupted the big-picture view of the market and prevent the healthy wash-out that is needed.

My game plan is to continue to watch for better price action in stocks that I favor. I want to buy relative strength in names with solid fundamentals and charts. Many great stocks are not extended, but they also have little technical support and can easily drift lower. I'm still optimistic about some strong action before the end of the year, and this Omicron uncertainty may eventually help create good bounce conditions.

Futures are off the early lows, but the negative speculation will keep some folks on the sidelines.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Rev Shark had no positions in any securities mentioned.

TAGS: Indexes | Markets | Small Cap | Stocks | Trading | U.S. Equity | Coronavirus

More from Markets

The 10 Personality Traits of Successful Traders and Investors

James "Rev Shark" DePorre
Jun 25, 2022 10:00 AM EDT

Superior market players share these characteristics in their emotional makeup.

The Best House in This Neighborhood Is on Sale

Brad Ginesin
Jun 24, 2022 12:15 PM EDT

The buying opportunity here below book value is compelling.

Here's Why It's Not Yet Time to Buy Retail Stocks

Bret Jensen
Jun 24, 2022 11:00 AM EDT

Something tells me there will plenty of 'Black Friday' bargains to be had this year.

Here's What We Need to See to Be Convinced the Market Has Turned

Guy Ortmann
Jun 24, 2022 10:28 AM EDT

The 'crowd' remains at historically levels of fear.

A Stock That Lets You Sleep Well at Night

Paul Price
Jun 24, 2022 7:00 AM EDT

This conservative, high-yielding stock has very tempting upside potential.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 12:10 AM EDT PAUL PRICE

    More Insider Buying in American Woodmark (AWMD)

    American Woodmark , which I've discussed here fr...
  • 08:55 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    The 10 personality traits of successful traders an...
  • 12:08 PM EDT STEPHEN GUILFOYLE

    Stocks Under $10

    As a Portfolio Name Agrees to a Merger, Here's Our...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login